Likewise, through WNT-1 inhibition, the miR-148a overexpression decreased the metastatic potential and lung colonization of murine 4T1 and human MDA-MB-231 cells in vivo [45], supporting the role of miR-148a as a breast cancer metastasis biomarker for the clinic. Here, WNT1 is linked to breast cancer.